News Your PsO Patients Can Use: Guselkumab Shows Significant Skin Clearance in Special Sites
Guselkumab (Tremfya, Johnson & Johnson) is highly effective in psoriasis patients with low body surface area (BSA), moderate plaque psoriasis with involvement of special sites, according to research presented at the 2025 Maui Derm Hawaii meeting. The new study was selected as a late breaker top five finalist for the best poster Akamai Award at […]